Beacon Medicare Limited organized a global business conference, upholding 10 years of glory of the company’s business in domestic and global markets at The Westin Dhaka in January 2020.
The conference on the theme of “10 years of Caring Global Patients” was held at the Ball room of Westin hotel in Dhaka on January 22, 2020, where employees and stakeholders from home and abroad took part.
The theme reflects the novel works of the pharmaceutical company for making cancer treatment affordable for people in the world.
In the conference Our Chairman Mr. MD. Ebadul Karim (MP), Executive Director of Beacon Pharmaceuticals, Mrs. Risana Karim, Director of Global Business Development Mr. Monjurul Alam, VP of Beacon Medicare Ltd. Mr. Shahariar Tamal Selim along with All the business executives and for the first time Field forces of different countries were present in the occasion
While addressing the function, Mohammad Ebadul Karim MP, Managing Director of Beacon Pharmaceuticals mentioned that the company is marching forward with a vision to keep a good sign in global pharmaceutical arena by serving cancer patients beyond the race and region.
Taking part in the programme, Ms. Risana Karim, executive director of the Beacon Pharmaceuticals Ltd, congratulated her field forces for achieving desired goal of the company for the last five consecutive years. Realizing sufferings of the cancer patients, Risana Karim, also expressed her outmost eagerness for serving the cancer patients worldwide.
Director of Global Business Development congratulated the full team for their effort and expressed his thanks to all the guests present on the function.
Md Golam Robbani, Director of plant, Nazmun Nahar Chowdhury, director of oncology, Mohammad Hanif, EVP of marketing, Anisur Rahman Khan, EVP of HR and Admin were also present at the programme.
Vice President of the BML Md Shahriar Tamal Selim said that Beacon is now a generic multinational company.
The BML is currently dealing operation with at least 30 countries around the globe. Not only this, the patients from 140 countries are now being taken care with the Beacon’s medicines, he added.
BML concluded the programme with launching of two products Nivolumab and Pembroxim.
Launching of Nivolunix and pembroxim.